新辅助治疗类型对肺袖状切除支气管吻合口愈合的影响
该研究基于前瞻性数据库分析2006至2017年501例肺癌袖状切除术患者,其中73%未行术前治疗、8%行新辅助化疗、19%行放化疗。标准化支气管镜评分显示,放化疗组吻合口愈合差于2级的比例达30%,吻合口功能不全率升至10.4%,均显著高于未治疗组和化疗组。
要点
- 新辅助放化疗组吻合口愈合差于2级的比例为30%,显著高于未治疗组的17%和化疗组的10%。
- 新辅助放化疗组吻合口功能不全率为10.4%,显著高于未治疗组的2.7%和化疗组的2.4%。
- 新辅助放疗与袖状切除术后吻合口愈合不良及吻合口功能不全风险升高相关。
核心结论
- 新辅助放疗与肺癌袖状切除术后支气管吻合口愈合不良相关,吻合口功能不全和并发症风险似乎更高。
研究设计与样本
- 前瞻性数据库研究,2006至2017年共501例袖状肺叶切除术,占所有肺癌切除的19%。
- 365例(73%)未行术前治疗,41例(8%)行新辅助化疗,95例(19%)行放化疗。
- 术后第七天以标准化评分系统行支气管镜评估吻合口愈合,必要时后续复查。
主要发现
- 吻合口愈合差于2级(评分1分极好至5分不足)的比例:未治疗组17%、化疗组10%、放化疗组30%(P = .002)。
- 吻合口功能不全率:未治疗组2.7%、化疗组2.4%、放化疗组10.4%(P = .002)。
- 肺部并发症风险:放化疗组39%、未治疗组29%、化疗组27%(P = .382)。
临床怎么用
- 对拟行袖状肺叶切除术的肺癌患者,若曾接受新辅助放化疗,应加强吻合口愈合的支气管镜监测。
- 新辅助放化疗患者术后需警惕吻合口功能不全及肺部并发症风险升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preoperative radiotherapy and/or chemotherapy of lung cancer in patients with locally advanced disease is an option in multimodal treatment. Sleeve lobectomy has an important part in decreasing complications and sparing lung function. We present our experience in a large cohort of patients after sleeve lobectomy with or without neoadjuvant treatment and standardized assessment of bronchial anastomotic healing. METHODS: The data used for this study were collected in a prospective database in our hospital. Anastomotic healing was documented by bronchoscopy on the seventh postoperative day and thereafter only when necessary, using a standardized scoring system. From 2006 to 2017, we performed 501 sleeve lobectomies representing 19% of all lung cancer resections. A total of 365 of patients had no preoperative treatment (73%), 41 had neoadjuvant chemotherapy (8%), and 95 had radiochemotherapy (19%). RESULTS: Using our scoring system of the bronchial anastomosis from 1 (excellent) to 5 (insufficient), we found the anastomosis was worse than grade 2 after no treatment, chemotherapy, or radiochemotherapy in 17%, 10%, and 30%, respectively (P = .002). The rate of anastomotic insufficiency was equally low after no pretreatment and chemotherapy (2.7% and 2.4%) and rose to 10.4% after radiotherapy (P = .002). Similarly, the risk for pulmonary complications was higher after radiochemotherapy (39%) compared with no pretreatment (29%) or chemotherapy (27%), respectively (P = .382). CONCLUSIONS: Neoadjuvant radiotherapy is associated with worse wound healing of the anastomosis after sleeve lobectomy in lung cancer. There seems to be a higher risk for anastomotic insufficiency and complications.
引用
- Koryllos A, Lopez-Pastorini A, Zalepugas D, et al. Bronchus Anastomosis Healing Depending on Type of Neoadjuvant Therapy. Ann Thorac Surg. 2019. PMID: 31843636. doi:10.1016/j.athoracsur.2019.10.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。